Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 11
Phase 29
Phase 38

Trial Status

Completed17

Role Distribution

Other Roles17

Activity Timeline

Research Network

Collaboration Network

1 collaborators·0 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Similar Key Opinion Leaders

Publications (0)

No publications found for this investigator.

Clinical Trials (17)

Showing 17 of 17 trials

NCT00667004Phase 2StudyDirector

Efficacy Study of Ecabet Ophthalmic Solution in Dry Eye Disease

Dry Eye Disease
Completed
NCT00198523Phase 3StudyDirector

A Bioequivalence Study of Tobramycin and Prednisolone Acetate Compared to PredForte

Eye InfectionsPostoperative Complications
Completed
NCT00198536Phase 2/3StudyDirector

Efficacy and Safety Study for Ecabet Ophthalmic Solution for Treating Dry Eye Syndrome

Dry Eye Syndromes
Completed
NCT00585975Phase 2StudyDirector

Efficacy and Safety of Bromfenac Ophthalmic Solution

Cataract Surgery
Completed
NCT00586625Phase 3StudyDirector

Safety Study for Bepotastine Besilate Ophthalmic Solution in Normal Volunteers

Allergic Conjunctivitis
Completed
NCT00586664Phase 3StudyDirector

Efficacy and Safety Study of Bepotastine Besilate Ophthalmic Solution in Allergic Conjunctivitis

Allergic Conjunctivitis
Completed
NCT00699803Phase 2StudyDirector

Study of T-PRED(TM) Compared to Pred Forte(R)

Cataract
Completed
NCT00758784Phase 2StudyDirector

Safety and Efficacy of an Ophthalmic Solution in Dry Eye Disease

Dry Eye Disease
Completed
NCT00853970Phase 3StudyDirector

Efficacy Study of Bromfenac Ophthalmic Solution in Patients Undergoing Cataract Surgery

InflammationPain
Completed
NCT00854061Phase 3StudyDirector

Study of T-PRED(TM) Compared to Pred Forte(R) II

Cataract
Completed
NCT01174823Phase 2StudyDirector

Safety and Efficacy of Bepotastine Besilate Ophthalmic Solution in Seasonal Allergic Conjunctivitis Patients

Allergic Conjunctivitis
Completed
NCT01212471Phase 3StudyDirector

A Dose Ranging Study to Evaluate Safety and Efficacy of Bromfenac Ophthalmic Solution in Dry Eye Disease

Dry Eye Syndrome
Completed
NCT01222299Phase 1/2StudyDirector

Safety, Pharmacokinetics, and Efficacy of Bepotastine Besilate Nasal Product After Ragweed Pollen Exposure in an Environmental Chamber

Seasonal Allergic Rhinitis
Completed
NCT01277341Phase 2StudyDirector

Safety and Efficacy of Bepotastine Besilate Nasal Spray in the Treatment of Seasonal Allergic Rhinitis

Seasonal Allergic Rhinitis
Completed
NCT01367249Phase 3StudyDirector

Efficacy of Bromfenac Ophthalmic Solution in Patients Undergoing Cataract Surgery

CataractInflammationPain
Completed
NCT01578278Phase 2StudyDirector

Bepotastine Besilate-corticosteroid Nasal Spray Combination Compared to Placebo, Bepotastine Besilate Nasal Spray, and Corticosteroid Nasal Spray in the Treatment of Patients With Seasonal Allergic Rhinitis

Seasonal Allergic Rhinitis
Completed
NCT01650584Not ApplicableStudyDirector

Evaluation of Ocular Comfort With ISTA Tears vs Systane

Dry Eye Disease
Completed

All 17 trials loaded